AVIDITY Trademark
AVIDITY is a USPTO trademark filed by Avidity Biosciences, Inc.. Status: Registered.
Trademark Facts
| Mark | AVIDITY |
|---|---|
| Serial Number | 88808578 |
| Registration Number | 6147100 |
| Status | Registered |
| Filing Date | 2020-02-24 |
| Registration Date | 2020-09-08 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | Avidity Biosciences, Inc. |
| Attorney of Record | Aaron D. Hendelman |
| Prosecution Events | 24 |
| Latest Event | CHAN on 2026-03-05 |
Goods & Services
Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics